BDBM697964 US20240317663, Compound V::des-D-19-nor-aB

SMILES [#6]-[#6@H]1-[#6@@H](-[#6]-[#6]-[#6]\[#6]-1=[#6]/[#6]=[#6]-1\[#6]-[#6@@H](-[#8])-[#6]-[#6@H](-[#8])-[#6]-1)-c1cccc(-[#8]-[#6]-[#6]C([#6])([#6])[#6])c1

InChI Key InChIKey=VBIFQCKCQBZDGA-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 697964   

TargetVitamin D3 receptor(Human)
Kanagawa University

US Patent
LigandPNGBDBM697964(des-D-19-nor-aB | US20240317663, Compound V)
Affinity DataEC50:  243nMAssay Description:A VDR ligand binding domain tagged with GST (VDR-LBD(GST)), a fluorescein-TRAP220/DRIP-2-bound coactivator peptide (Fluorescein-peptide), LanthaScree...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
Go to US Patent